Low Dose Aspirin vs Placebo in Prevention of Recurrent Spontaneous Preterm Labour
NCT: NCT07745595 · NOT_YET_RECRUITING
Brief Summary
Abnormal Uterine Bleeding (AUB) is a common gynecological issue affecting women globally, requiring endometrial tissue sampling to evaluate underlying causes such as hyperplasia, polyps, or malignancy. While Pipelle biopsy is a widely used outpatient sampling technique, its single-use nature makes it relatively expensive in resource-limited settings. Manual Vacuum Aspiration (MVA) using a 4 mm flexible cannula is an inexpensive, reusable alternative that requires no cervical dilation or electricity, but direct comparative evidence between MVA and Pipelle remains limited
Frequently Asked Questions
What is Low Dose Aspirin vs Placebo in Prevention of Recurrent Spontaneous Preterm Labour?
Low Dose Aspirin vs Placebo in Prevention of Recurrent Spontaneous Preterm Labour is a clinical trial registered under NCT07745595. Current status: NOT_YET_RECRUITING.
What is the status of NCT07745595?
The current status of NCT07745595 (Low Dose Aspirin vs Placebo in Prevention of Recurrent Spontaneous Preterm Labour) is: NOT_YET_RECRUITING.
When did Low Dose Aspirin vs Placebo in Prevention of Recurrent Spontaneous Preterm Labour start?
Low Dose Aspirin vs Placebo in Prevention of Recurrent Spontaneous Preterm Labour started on 2026-08-20.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.